Nucleic Acid Point-of-Care Testing to Improve Diagnostic Preparedness
Clin. infect. dis; 75 (4), 2022
Testing programs for severe acute respiratory syndrome coronavirus 2 have relied on high-throughput polymerase chain reaction laboratory tests and rapid antigen assays to meet diagnostic needs. Both technologies are essential; however, issues of cost, accessibility, manufacturing delays, and performance ...